Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
NYC patients face specific challenges regarding insurance coverage, including strict exclusions for weight loss under NYRx Medicaid
Each case depends on maternal health urgency, infant age, and availability of other evidence-based options
The final 18 months are for refining the model with arriving competitive intelligence data, payer contract negotiations, and litigation outcomes
Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
US$ 27.37
US$ 27.36
US$ 23.46
US$ 28.29
US$ 23.55
US$ 28.31
US$ 20.88
